Rate My Professor Stephen Doughty

Professor Stephen Doughty serves as Professor of Pharmacy and Head of Pharmacy Programme at Bangor University’s North Wales Medical School. In January 2025, he was appointed Head of the North Wales Medical School. Previously, he acted as Interim Head of the Centre for the Enhancement of Learning and Teaching at the North Wales School of Education and as Professor of Pharmacy and Head of Pharmacy Programme in the School of Health Sciences. Professor Doughty has played a pivotal role in launching Bangor University’s Master of Pharmacy programme, which began in 2025 to address shortages of pharmacists in North Wales and support national healthcare needs. He led public, patient, and stakeholder input activities for this degree from April to June 2024. As a member of the University Council, appointed by academic staff, he contributes to institutional governance. His leadership extends to initiatives like the 2025 unveiling of the Welsh herbal garden at Treborth Botanic Garden, enhancing medicinal plant education, and participation in clinical research symposia and experiential learning events.

Professor Doughty’s research focuses on molecular modelling of G-protein coupled receptors (GPCRs) and membrane-bound receptors, as well as computer-aided drug design. He has supervised postgraduate projects in these areas and produced nine peer-reviewed research outputs spanning 1997 to 2018. Key publications include: “Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment” (2018, Journal of Molecular Graphics and Modelling, with Loo, J. S. E. et al.); “Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT2 and α1 receptor antagonists” (2018, MedChemComm, with Heng, H. L. et al.); “Homology modeling of the human 5-HT1A, 5-HT2A, D1, and D2 receptors: Model refinement with molecular dynamics simulations and Docking evaluation” (2012, Journal of Molecular Modeling, with Yap, B. K. et al.); “Crystallization and preliminary X-ray characterization of the Bacillus amyloliquefaciens YwrO enzyme” (2007, Acta Crystallographica Section F, with AbuKhader, M. M. et al.); and “Inhibition of cobalamin-dependent methionine synthase by substituted benzo-fused heterocycles” (2007, FEBS Journal, with Banks, E. C. et al.). His contributions advance computational approaches to pharmacology and support regional healthcare innovation.